Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
| $7.37M | ﹤0.01% |
74,710
+54,730
| +274% | +$4.52M |
|
|
TBCH
3027
CALL
Turtle Beach Corp
TBCH
$228M
| $7.36M | ﹤0.01% |
601,500
+156,700
| +35% | +$2.67M |
|
3028
Deluxe
DLX
$1.1B
| $7.35M | ﹤0.01% |
339,012
+173,249
| +105% | +$4.41M |
|
|
BPMC
3029
CALL
DELISTED
Blueprint Medicines
BPMC
| $7.34M | ﹤0.01% |
145,400
+137,200
| +1,673% | +$8.04M |
|
|
AONC
3030
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $7.34M | ﹤0.01% |
750,631
+609
| +0.1% | +$5.96K |
|
3031
PUT
Freshpet
FRPT
$3.5B
| $7.32M | ﹤0.01% |
141,100
+116,000
| +462% | +$8.95M |
|
3032
iShares TIPS Bond ETF
TIP
$14.7B
| $7.32M | ﹤0.01% |
64,249
-27,605
| -30% | -$3.27M |
|
3033
MaxLinear
MXL
$7.69B
| $7.31M | ﹤0.01% |
215,017
+206,676
| +2,478% | +$8.66M |
|
3034
CALL
United Therapeutics
UTHR
$21.4B
| $7.3M | ﹤0.01% |
31,000
-49,500
| -61% | -$10.1M |
|
3035
TG Therapeutics
TGTX
$7.46B
| $7.3M | ﹤0.01% |
1,717,444
+640,516
| +59% | +$4M |
|
|
COOP
3036
CALL
DELISTED
Mr. Cooper
COOP
| $7.3M | ﹤0.01% |
198,600
+13,300
| +7% | +$563K |
|
3037
KeyCorp
KEY
$25B
| $7.29M | ﹤0.01% |
423,349
-2,244,104
| -84% | -$43.4M |
|
3038
Northrop Grumman
NOC
$83.2B
| $7.29M | ﹤0.01% |
15,238
+3,920
| +35% | +$1.8M |
|
3039
Boise Cascade
BCC
$2.9B
| $7.29M | ﹤0.01% |
122,538
-4,085
| -3% | -$301K |
|
3040
PUT
Sprout Social
SPT
$599M
| $7.29M | ﹤0.01% |
125,500
-33,900
| -21% | -$1.97M |
|
3041
CoreCivic
CXW
$3.25B
| $7.29M | ﹤0.01% |
655,734
+161,748
| +33% | +$1.95M |
|
3042
PUT
Mid-America Apartment Communities
MAA
$15.5B
| $7.28M | ﹤0.01% |
41,700
+800
| +2% | +$149K |
|
|
FHLT
3043
DELISTED
Future Health ESG Corp. Common stock
FHLT
| $7.28M | ﹤0.01% |
735,712
+69,273
| +10% | +$686K |
|
|
ANSS
3044
CALL
DELISTED
Ansys
ANSS
| $7.27M | ﹤0.01% |
30,400
-4,400
| -13% | -$1.16M |
|
|
SHAC
3045
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $7.27M | ﹤0.01% |
742,889
-502,455
| -40% | -$4.93M |
|
3046
CALL
Lemonade
LMND
$4.07B
| $7.26M | ﹤0.01% |
397,700
-32,500
| -8% | -$685K |
|
3047
PUT
Vanguard Dividend Appreciation ETF
VIG
$114B
| $7.26M | ﹤0.01% |
50,600
+24,400
| +93% | +$3.71M |
|
3048
CALL
Pan American Silver
PAAS
$19.7B
| $7.26M | ﹤0.01% |
369,000
-210,500
| -36% | -$5.05M |
|
3049
Kforce
KFRC
$1.04B
| $7.25M | ﹤0.01% |
118,133
+50,549
| +75% | +$3.45M |
|
3050
PUT
Range Resources
RRC
$9.42B
| $7.24M | ﹤0.01% |
292,500
+96,600
| +49% | +$2.96M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.